CoreAge Rx vs Bon Health
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Bon Health head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 63 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Bon Health a bad call — it's best for readers comparing prepaid compounded plans who obtain the patient agreement and total commitment before choosing the lowest equivalent rate. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Bon Health |
|---|---|---|
| Brief Score | 94/100 (A) | 63/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | $220 monthly or $1,140 yearly Other terms: $420 every three months or $690 every six months. The $95/month equivalent requires the full yearly charge. Medication, support, supplies and delivery advertised included; selected dose/quantity and governing patient refund agreement unconfirmed. Full price detailsCompounded semaglutide injection offered; complete selected-prescription quote unknown; advertised $220 monthly, $420 every three months, $690 every six months or $1,140 yearly ($95/month equivalent) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $285 monthly or $1,620 yearly Other terms: $615 every three months or $1,110 every six months. The $135/month equivalent requires the full yearly charge. No separate membership fee advertised; confirm selected prescription, pharmacy and unused-prepaid cancellation/refund calculation. Full price detailsCompounded tirzepatide injection offered; complete selected-prescription quote unknown; advertised $285 monthly, $615 every three months, $1,110 every six months or $1,620 yearly ($135/month equivalent) |
| Coverage | US only; restrictions by state, confirmed at intake | Nationwide clinician coverage advertised, but actual medication availability varies by state and partner clinical/pharmacy coverage |
| Brand-name access | Not confirmed | Homepage separately advertises Wegovy, Ozempic, Zepbound and Mounjaro; confirm the selected brand, prescription eligibility and full pharmacy charge. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Bon Health: $95/$135 equivalents require $1140/$1620 annual charges; monthly options $220/$285. Complete selected prescription and patient cancellation/refund agreement unconfirmed.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.